![James Neal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Neal
Direktör/Styrelseledamot på
PROCESSA PHARMACEUTICALS, INC.
Förmögenhet: 2 504 $ per 2025-05-31
Profil
James R.
Neal is currently Chief Executive Officer at XOMA (US) LLC, Independent Director at Processa Pharmaceuticals, Inc. since 2022, and Independent Director at Monterey Innovation Acquisition Corp.
since 2021.
Former positions include Chief Executive Officer & Director at Iconix Biosciences, Inc. from 2002 to 2007, President & Chief Executive Officer at Entelos, Inc. in 2009, Chief Executive Officer at US Food & Drug Administration, Chairman & Chief Executive Officer at XOMA Royalty Corp.
from 2021 to 2023, Chairman at Seneca Biopharma, Inc., Chairman at Palisade Bio, Inc. from 2021 to 2024, Director at Leading Biosciences, Inc., Lead Independent Director at Peak Bio, Inc. from 2022 to 2024, Independent Director at Akari Therapeutics Plc from 2024 to 2026, Principal at Monsanto Co. from 1997 to 1999, General Manager at The Solaris Group in 1999, EVP-Sales, Marketing & Business Development at Incyte Genomics Inc. from 1999 to 2002, Partner at Eli Lilly & Co. Ltd., and Partner at GlaxoSmithKline Pharmaceuticals SA (Belgium).
Education includes an MBA from Washington University in St. Louis in 1992 and undergraduate and graduate degrees from the University of Manitoba.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-26 | 1 021 ( 0,04 % ) | 2 093 $ | 2026-08-31 | |
AKARI THERAPEUTICS PLC 0,03 % | 2026-06-01 | 41 144 000 ( 0,03 % ) | 411 $ | 2025-05-31 |
Aktiva positioner av James Neal
| Företag | Position | Start |
|---|---|---|
| MONTEREY INNOVATION ACQUISITION CORP. | Direktör/Styrelseledamot | 2023-03-09 |
| PROCESSA PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2022-07-16 |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Verkställande Direktör | - |
Tidigare kända positioner av James Neal
| Företag | Position | Slut |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Direktör/Styrelseledamot | 2026-06-30 |
| PEAK BIO, INC. | Direktör/Styrelseledamot | 2024-11-14 |
| PALISADE BIO, INC. | Ordförande | 2024-02-09 |
| XOMA ROYALTY CORPORATION | Verkställande Direktör | 2023-01-01 |
| PALISADE BIO, INC. | Ordförande | 2021-04-29 |
James Neals utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
67
Första gradens relationer
19
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 19 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Iconix Biosciences, Inc.
 Iconix Biosciences, Inc. BiotechnologyHealth Technology Provides toxicogenomics products and services | Health Technology |
Entelos, Inc.
 Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
The Solaris Group
 The Solaris Group Chemicals: AgriculturalProcess Industries Manufactures plant food | Process Industries |
Incyte Genomics Inc. /Micoarray Operations/
 Incyte Genomics Inc. /Micoarray Operations/ Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical drug discovery and development services | Commercial Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Leading Biosciences, Inc.
 Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Monterey Innovation Acquisition Corp.
 Monterey Innovation Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Peak Bio, Inc.
 Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
